Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

STAAR Surgical Company - Common Stock (NQ:STAA)

17.54 +0.87 (+5.22%)
Streaming Delayed Price Updated: 11:49 AM EDT, Jun 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Which stocks are moving after the closing bell on Tuesday?
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results
From STAAR Surgical Company
Via Business Wire
Don't overlook NASDAQ:STAA—a stock with solid growth prospects and a reasonable valuation.
STAAR SURGICAL CO was identified as a growth stock that isn't overvalued. NASDAQ:STAA is excelling in various growth indicators while maintaining a solid financial footing. 
Via Chartmill
Why NASDAQ:STAA Is a Promising High-Growth Stock in the Midst of Consolidation.
Is STAAR SURGICAL CO (NASDAQ:STAA) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
NASDAQ:STAA, a growth stock which is not overvalued.
Despite its growth, STAAR SURGICAL CO (NASDAQ:STAA) remains within the realm of affordability. 
Via Chartmill
Despite its growth, NASDAQ:STAA remains within the realm of affordability.
STAAR SURGICAL CO (NASDAQ:STAA), a growth stock which is not overvalued. 
Via Chartmill
In the world of growth stocks, NASDAQ:STAA shines as a value proposition.
Investors should take note of NASDAQ:STAA, a growth stock that remains attractively priced. 
Via Chartmill
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
From STAAR Surgical Company
Via Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
Investors should take note of NASDAQ:STAA, a growth stock that remains attractively priced.
Investors seeking growth at a reasonable cost should explore STAAR SURGICAL CO (NASDAQ:STAA). 
Via Chartmill
STAAR Surgical to Participate in BTIG Ophthalmology Day
From STAAR Surgical Company
Via Business Wire
Exploring Staar Surgical's Earnings Expectations
Via Benzinga
Investors seeking growth at a reasonable cost should explore NASDAQ:STAA.
Looking for growth without the hefty price tag? Consider STAAR SURGICAL CO (NASDAQ:STAA). 
Via Chartmill
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
From STAAR Surgical Company
Via Business Wire
CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Third Quarter Results on October 30, 2024
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
From STAAR Surgical Company
Via Business Wire
Analyst Scoreboard: 4 Ratings For Staar Surgical
Via Benzinga
Analyst Expectations For Staar Surgical's Future
Via Benzinga
Sidoti Events, LLC's Virtual September Small-Cap Conference
Via ACCESSWIRE
For those who appreciate growth without the sticker shock, NASDAQ:STAA is worth considering.
Don't overlook NASDAQ:STAA—a stock with solid growth prospects and a reasonable valuation. 
Via Chartmill
A Glimpse Into The Expert Outlook On Staar Surgical Through 4 Analysts
Via Benzinga
STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q2 2024
STAA stock results show that Staar Surgical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
STAAR Surgical Reports Second Quarter 2024 Results
From STAAR Surgical Company
Via Business Wire
Expert Outlook: Staar Surgical Through The Eyes Of 5 Analysts
Via Benzinga
STAAR Surgical to Report Second Quarter Results on August 7, 2024
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference
From STAAR Surgical Company
Via Business Wire
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
Top performers last week: Tempus AI +30%, Enovix Corp +29%, Grindr Inc +27.5%, Trump Media +18.33%, Credo Tech +18.3%, Tecnoglass Inc +17.9%, STAAR Surgical +16.55%, RXO Inc +16.22%, Global-E Online... 
Via Benzinga
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Staar Surgical Stock Earns RS Rating Upgrade
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.